Purpose: The pharmacology, pharmaceutics, clinical efficacy, adverse effects, cost, and dosage and administration of long-acting risperidone injection are reviewed. Summary: Risperidone is the first ...
The FDA approval was supported by data from the BLISS-SC Phase 3 study (n>800) in patients with active SLE. GlaxoSmithKline announced that the Food and Drug Administration (FDA) has approved Benlysta ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results